TraceLink has officially announced a partnership with RSM US LLP, the leading provider of assurance, tax and consulting services for the middle market. According to certain reports, the stated partnership is geared towards helping HLS (health and life sciences) leaders in supply chain, finance, and information technology gain access to a unified capability for rapidly linking their enterprise systems with a pre-authenticated digital network of more than 290,000 entities. To get there, the development will combine TraceLink’s proven platform for end-to-end network integration, collaboration, and supply chain intelligence with RSM’s specialized consulting, all of it done to put-together a streamlined “single-vendor approach.” This approach can then be leveraged to acquire access to the real-time supply chain information. As for the stated information, once collected, it can prove useful in the context of accelerating new products to market, reducing manufacturing costs and working capital requirements, and optimizing the efficiency of global, multi-enterprise workforces. Talk about the whole collaboration on a slightly deeper level, we begin from the promise of unified integration and collaboration, where beneficiaries can leverage TraceLink’s Integrate-Once, Interoperate with Everyoneâ„¢ approach through MINT to achieve a single point of integration for all supply chain partners. Put that alongside RSM’s comprehensive knowledge, and you should be able to streamline operations and strengthen inventory control.
Next up, we must get into how the given partnership can ensure accelerated market entry. Here, the idea is to get TraceLink and RSM to jointly facilitate rapid drug commercialization, merging RSM’s launch support with seamless ERP integration for faster development-to-market transitions. Moving on to the potential present when it comes to decision-making and efficiency. This involves, at its core, integration of a complete supply chain view into your ERP systems, supported by RSM’s specialized consulting, for superior decision-making and peak operational efficiency.
“Through my engagements with senior executives at leading Pharmaceutical, Life Sciences, and Healthcare organizations, it’s clear that leaders recognize that, despite billions of dollars in enterprise system investments over the last decade, there is a critical need to acquire real-time, end-to-end supply chain intelligence and visibility to mitigate supply disruptions and ensure the continuous availability of products for patients,” said Shabbir Dahod, President and CEO of TraceLink.
Hold on, we still have a few bits left to unpack, considering we still haven’t acknowledged the way this collaboration will improve upon experience in compliance and performance. By that, we refer to how users can expect to achieve adherence to international regulations, including US Drug Supply Chain Security Act and EU Falsified Medicines Directive, while simultaneously enjoying the option to access expert advice for system optimization. Rounding up highlights is a facility to optimize financial operations. This particular facility will bank upon RSM’s Financial Reconciliation services, supercharged with real-time supply chain information sourced from the TraceLink network, including chargebacks, enhance financial transparency and efficiency.
“We are incredibly excited about teaming up with TraceLink,” said Joe Goldberg, management consulting partner and life sciences advisory practice leader with RSM US LLP. “This alliance allows us to combine our deep industry experience and service offerings with TraceLink’s advanced supply chain orchestration technologies, providing our clients with unparalleled service and capabilities. We’re looking forward to continuing to offer holistic, innovative solutions to the life sciences industry and are excited about the positive impact this collaboration will have on our clients’ businesses and the industry as a whole.”